Litigation Details for GENENTECH, INC. v. SANDOZ, INC. (D.N.J. 2023)
✉ Email this page to a colleague
GENENTECH, INC. v. SANDOZ, INC. (D.N.J. 2023)
| Docket | ⤷ Sign Up | Date Filed | 2023-07-31 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | |
| Jury Demand | Referred To | Leda Dunn Wettre | |
| Patents | 10,188,637 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in GENENTECH, INC. v. SANDOZ, INC.
The small molecule drug covered by the patent cited in this case is ⤷ Sign Up .
Details for GENENTECH, INC. v. SANDOZ, INC. (D.N.J. 2023)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2024-03-05 | 56 | Opinion | infringement of United States Patent No. 10,188,637 (the “’637 Patent” or the “Patent”). (ECF No. 1 (“Compl.”…method-of-treatment patents; none was a formulation patent like the ‘637 Patent. See id. No formulation patent was …the Patent here is completely unrelated to the patents tried by Judge Andrews. While the Patent in … HLR owns the Patent, and Genentech exclusively licenses it. (Id. ¶ 16). The Patent claims a novel tablet…disease. (Id. ¶ 1 & Exh. 1). The Patent is one of twenty-one patents listed in the Food and Drug Administration | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
